JLHL Jupiter Life Line Hospitals Q2 FY26 results (Jul–Sep 2025) and concall
Jupiter Life Line Hospitals reported a solid Q2 and H1 FY26, with operating income growing 11.7% and 14.9% year-on-year respectively. EBITDA margins remained healthy at 22.8% for Q2 and 22.5% for H1. The company is on track with its expansion plans, with the Dombivali Hospital expected to commence operations in Q1 FY27 and construction for South Pune Hospital initiated. However, a one-time provision in professional fees and anticipated initial margin dilution from new hospitals were noted.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|
| Revenue | 270 | 274 | 278 | 316 |
| EBITDA | 69 | 72 | 68 | 79 |
| Net profit | 49 | 44 | 43 | 55 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
